BDBM636706 US20230365627, Compound 1031

SMILES CCCC[C@@H]1N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@@H]2Cc3cn(CC(=O)OB(O)c4cc(F)c(F)cc4CNC[C@@H]4NC(=O)[C@@H]5CCCN5C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc5ccc(OB(O)c6cc(F)c(F)cc6CNCC[C@H](NC(=O)[C@H](Cc6c[nH]c7ccccc67)NC(=O)[C@@H]6C[C@@H](O)CN6C(=O)[C@H](CC(C)C)NC4=O)C(=O)N2)cc5)NC(=O)CSC[C@H](NC(=O)[C@H](CC(C)C)NC1=O)C(=O)NCC(N)=O)c1ccccc31

InChI Key InChIKey=YBSWBPPWOMXYRT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 636706   

TargetProgrammed cell death 1 ligand/protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM636706(US20230365627, Compound 1031)
Affinity DataIC50: 10nMAssay Description:Homogenous Time-Resolved Fluorescence (HTRF) Binding Assay. The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/16/2024
Entry Details
Go to US Patent